COVID-19 Impact on Global Targeted DNA/RNA Sequencing Market Size, Status and Forecast 2020-2026

COVID-19 Impact on Global Targeted DNA/RNA Sequencing Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Targeted DNA/RNA Sequencing Revenue
1.4 Market Analysis by Type
1.4.1 Global Targeted DNA/RNA Sequencing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 DNA-based Targeted Sequencing
1.4.3 RNA-based Targeted Sequencing
1.5 Market by Application
1.5.1 Global Targeted DNA/RNA Sequencing Market Share by Application: 2020 VS 2026
1.5.2 Human Biomedical Research
1.5.3 Plant & Animal Sciences
1.5.4 Drug Discovery
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Targeted DNA/RNA Sequencing Industry Impact
1.6.1 How the Covid-19 is Affecting the Targeted DNA/RNA Sequencing Industry
1.6.1.1 Targeted DNA/RNA Sequencing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Targeted DNA/RNA Sequencing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Targeted DNA/RNA Sequencing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Targeted DNA/RNA Sequencing Market Perspective (2015-2026)
2.2 Targeted DNA/RNA Sequencing Growth Trends by Regions
2.2.1 Targeted DNA/RNA Sequencing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Targeted DNA/RNA Sequencing Historic Market Share by Regions (2015-2020)
2.2.3 Targeted DNA/RNA Sequencing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Targeted DNA/RNA Sequencing Market Growth Strategy
2.3.6 Primary Interviews with Key Targeted DNA/RNA Sequencing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Targeted DNA/RNA Sequencing Players by Market Size
3.1.1 Global Top Targeted DNA/RNA Sequencing Players by Revenue (2015-2020)
3.1.2 Global Targeted DNA/RNA Sequencing Revenue Market Share by Players (2015-2020)
3.1.3 Global Targeted DNA/RNA Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Targeted DNA/RNA Sequencing Market Concentration Ratio
3.2.1 Global Targeted DNA/RNA Sequencing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Targeted DNA/RNA Sequencing Revenue in 2019
3.3 Targeted DNA/RNA Sequencing Key Players Head office and Area Served
3.4 Key Players Targeted DNA/RNA Sequencing Product Solution and Service
3.5 Date of Enter into Targeted DNA/RNA Sequencing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Targeted DNA/RNA Sequencing Historic Market Size by Type (2015-2020)
4.2 Global Targeted DNA/RNA Sequencing Forecasted Market Size by Type (2021-2026)
5 Targeted DNA/RNA Sequencing Breakdown Data by Application (2015-2026)
5.1 Global Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)
5.2 Global Targeted DNA/RNA Sequencing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Targeted DNA/RNA Sequencing Market Size (2015-2020)
6.2 Targeted DNA/RNA Sequencing Key Players in North America (2019-2020)
6.3 North America Targeted DNA/RNA Sequencing Market Size by Type (2015-2020)
6.4 North America Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Targeted DNA/RNA Sequencing Market Size (2015-2020)
7.2 Targeted DNA/RNA Sequencing Key Players in Europe (2019-2020)
7.3 Europe Targeted DNA/RNA Sequencing Market Size by Type (2015-2020)
7.4 Europe Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)
8 China
8.1 China Targeted DNA/RNA Sequencing Market Size (2015-2020)
8.2 Targeted DNA/RNA Sequencing Key Players in China (2019-2020)
8.3 China Targeted DNA/RNA Sequencing Market Size by Type (2015-2020)
8.4 China Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Targeted DNA/RNA Sequencing Market Size (2015-2020)
9.2 Targeted DNA/RNA Sequencing Key Players in Japan (2019-2020)
9.3 Japan Targeted DNA/RNA Sequencing Market Size by Type (2015-2020)
9.4 Japan Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Targeted DNA/RNA Sequencing Market Size (2015-2020)
10.2 Targeted DNA/RNA Sequencing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Targeted DNA/RNA Sequencing Market Size by Type (2015-2020)
10.4 Southeast Asia Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)
11 India
11.1 India Targeted DNA/RNA Sequencing Market Size (2015-2020)
11.2 Targeted DNA/RNA Sequencing Key Players in India (2019-2020)
11.3 India Targeted DNA/RNA Sequencing Market Size by Type (2015-2020)
11.4 India Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Targeted DNA/RNA Sequencing Market Size (2015-2020)
12.2 Targeted DNA/RNA Sequencing Key Players in Central & South America (2019-2020)
12.3 Central & South America Targeted DNA/RNA Sequencing Market Size by Type (2015-2020)
12.4 Central & South America Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Illumina, Inc.
13.1.1 Illumina, Inc. Company Details
13.1.2 Illumina, Inc. Business Overview and Its Total Revenue
13.1.3 Illumina, Inc. Targeted DNA/RNA Sequencing Introduction
13.1.4 Illumina, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020))
13.1.5 Illumina, Inc. Recent Development
13.2 F. Hoffmann-La Roche Ltd
13.2.1 F. Hoffmann-La Roche Ltd Company Details
13.2.2 F. Hoffmann-La Roche Ltd Business Overview and Its Total Revenue
13.2.3 F. Hoffmann-La Roche Ltd Targeted DNA/RNA Sequencing Introduction
13.2.4 F. Hoffmann-La Roche Ltd Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
13.2.5 F. Hoffmann-La Roche Ltd Recent Development
13.3 Agilent Technologies
13.3.1 Agilent Technologies Company Details
13.3.2 Agilent Technologies Business Overview and Its Total Revenue
13.3.3 Agilent Technologies Targeted DNA/RNA Sequencing Introduction
13.3.4 Agilent Technologies Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
13.3.5 Agilent Technologies Recent Development
13.4 GATC Biotech Ag
13.4.1 GATC Biotech Ag Company Details
13.4.2 GATC Biotech Ag Business Overview and Its Total Revenue
13.4.3 GATC Biotech Ag Targeted DNA/RNA Sequencing Introduction
13.4.4 GATC Biotech Ag Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
13.4.5 GATC Biotech Ag Recent Development
13.5 Oxford Nanopore Technologies
13.5.1 Oxford Nanopore Technologies Company Details
13.5.2 Oxford Nanopore Technologies Business Overview and Its Total Revenue
13.5.3 Oxford Nanopore Technologies Targeted DNA/RNA Sequencing Introduction
13.5.4 Oxford Nanopore Technologies Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
13.5.5 Oxford Nanopore Technologies Recent Development
13.6 Thermo Fisher Scientific, Inc.
13.6.1 Thermo Fisher Scientific, Inc. Company Details
13.6.2 Thermo Fisher Scientific, Inc. Business Overview and Its Total Revenue
13.6.3 Thermo Fisher Scientific, Inc. Targeted DNA/RNA Sequencing Introduction
13.6.4 Thermo Fisher Scientific, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
13.6.5 Thermo Fisher Scientific, Inc. Recent Development
13.7 DNASTAR Inc.
13.7.1 DNASTAR Inc. Company Details
13.7.2 DNASTAR Inc. Business Overview and Its Total Revenue
13.7.3 DNASTAR Inc. Targeted DNA/RNA Sequencing Introduction
13.7.4 DNASTAR Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
13.7.5 DNASTAR Inc. Recent Development
13.8 QIAGEN
13.8.1 QIAGEN Company Details
13.8.2 QIAGEN Business Overview and Its Total Revenue
13.8.3 QIAGEN Targeted DNA/RNA Sequencing Introduction
13.8.4 QIAGEN Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
13.8.5 QIAGEN Recent Development
13.9 BGI
13.9.1 BGI Company Details
13.9.2 BGI Business Overview and Its Total Revenue
13.9.3 BGI Targeted DNA/RNA Sequencing Introduction
13.9.4 BGI Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
13.9.5 BGI Recent Development
13.10 Perkin Elmer, Inc.
13.10.1 Perkin Elmer, Inc. Company Details
13.10.2 Perkin Elmer, Inc. Business Overview and Its Total Revenue
13.10.3 Perkin Elmer, Inc. Targeted DNA/RNA Sequencing Introduction
13.10.4 Perkin Elmer, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
13.10.5 Perkin Elmer, Inc. Recent Development
13.11 Pacific Biosciences of California, Inc.
10.11.1 Pacific Biosciences of California, Inc. Company Details
10.11.2 Pacific Biosciences of California, Inc. Business Overview and Its Total Revenue
10.11.3 Pacific Biosciences of California, Inc. Targeted DNA/RNA Sequencing Introduction
10.11.4 Pacific Biosciences of California, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
10.11.5 Pacific Biosciences of California, Inc. Recent Development
13.12 Bio-Rad Laboratories, Inc.
10.12.1 Bio-Rad Laboratories, Inc. Company Details
10.12.2 Bio-Rad Laboratories, Inc. Business Overview and Its Total Revenue
10.12.3 Bio-Rad Laboratories, Inc. Targeted DNA/RNA Sequencing Introduction
10.12.4 Bio-Rad Laboratories, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
10.12.5 Bio-Rad Laboratories, Inc. Recent Development
13.13 Integrated DNA Technologies, Inc.
10.13.1 Integrated DNA Technologies, Inc. Company Details
10.13.2 Integrated DNA Technologies, Inc. Business Overview and Its Total Revenue
10.13.3 Integrated DNA Technologies, Inc. Targeted DNA/RNA Sequencing Introduction
10.13.4 Integrated DNA Technologies, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
10.13.5 Integrated DNA Technologies, Inc. Recent Development
13.14 RainDance Technologies, Inc.
10.14.1 RainDance Technologies, Inc. Company Details
10.14.2 RainDance Technologies, Inc. Business Overview and Its Total Revenue
10.14.3 RainDance Technologies, Inc. Targeted DNA/RNA Sequencing Introduction
10.14.4 RainDance Technologies, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
10.14.5 RainDance Technologies, Inc. Recent Development
13.15 PierianDx
10.15.1 PierianDx Company Details
10.15.2 PierianDx Business Overview and Its Total Revenue
10.15.3 PierianDx Targeted DNA/RNA Sequencing Introduction
10.15.4 PierianDx Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
10.15.5 PierianDx Recent Development
13.16 Genomatix GmbH
10.16.1 Genomatix GmbH Company Details
10.16.2 Genomatix GmbH Business Overview and Its Total Revenue
10.16.3 Genomatix GmbH Targeted DNA/RNA Sequencing Introduction
10.16.4 Genomatix GmbH Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
10.16.5 Genomatix GmbH Recent Development
13.17 Macrogen, Inc.
10.17.1 Macrogen, Inc. Company Details
10.17.2 Macrogen, Inc. Business Overview and Its Total Revenue
10.17.3 Macrogen, Inc. Targeted DNA/RNA Sequencing Introduction
10.17.4 Macrogen, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
10.17.5 Macrogen, Inc. Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Targeted DNA/RNA Sequencing Key Market Segments
Table 2. Key Players Covered: Ranking by Targeted DNA/RNA Sequencing Revenue
Table 3. Ranking of Global Top Targeted DNA/RNA Sequencing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Targeted DNA/RNA Sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of DNA-based Targeted Sequencing
Table 6. Key Players of RNA-based Targeted Sequencing
Table 7. COVID-19 Impact Global Market: (Four Targeted DNA/RNA Sequencing Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Targeted DNA/RNA Sequencing Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Targeted DNA/RNA Sequencing Players to Combat Covid-19 Impact
Table 12. Global Targeted DNA/RNA Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Targeted DNA/RNA Sequencing Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Targeted DNA/RNA Sequencing Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Targeted DNA/RNA Sequencing Market Share by Regions (2015-2020)
Table 16. Global Targeted DNA/RNA Sequencing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Targeted DNA/RNA Sequencing Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Targeted DNA/RNA Sequencing Market Growth Strategy
Table 22. Main Points Interviewed from Key Targeted DNA/RNA Sequencing Players
Table 23. Global Targeted DNA/RNA Sequencing Revenue by Players (2015-2020) (Million US$)
Table 24. Global Targeted DNA/RNA Sequencing Market Share by Players (2015-2020)
Table 25. Global Top Targeted DNA/RNA Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted DNA/RNA Sequencing as of 2019)
Table 26. Global Targeted DNA/RNA Sequencing by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Targeted DNA/RNA Sequencing Product Solution and Service
Table 29. Date of Enter into Targeted DNA/RNA Sequencing Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Targeted DNA/RNA Sequencing Market Size by Type (2015-2020) (Million US$)
Table 32. Global Targeted DNA/RNA Sequencing Market Size Share by Type (2015-2020)
Table 33. Global Targeted DNA/RNA Sequencing Revenue Market Share by Type (2021-2026)
Table 34. Global Targeted DNA/RNA Sequencing Market Size Share by Application (2015-2020)
Table 35. Global Targeted DNA/RNA Sequencing Market Size by Application (2015-2020) (Million US$)
Table 36. Global Targeted DNA/RNA Sequencing Market Size Share by Application (2021-2026)
Table 37. North America Key Players Targeted DNA/RNA Sequencing Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Targeted DNA/RNA Sequencing Market Share (2019-2020)
Table 39. North America Targeted DNA/RNA Sequencing Market Size by Type (2015-2020) (Million US$)
Table 40. North America Targeted DNA/RNA Sequencing Market Share by Type (2015-2020)
Table 41. North America Targeted DNA/RNA Sequencing Market Size by Application (2015-2020) (Million US$)
Table 42. North America Targeted DNA/RNA Sequencing Market Share by Application (2015-2020)
Table 43. Europe Key Players Targeted DNA/RNA Sequencing Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Targeted DNA/RNA Sequencing Market Share (2019-2020)
Table 45. Europe Targeted DNA/RNA Sequencing Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Targeted DNA/RNA Sequencing Market Share by Type (2015-2020)
Table 47. Europe Targeted DNA/RNA Sequencing Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Targeted DNA/RNA Sequencing Market Share by Application (2015-2020)
Table 49. China Key Players Targeted DNA/RNA Sequencing Revenue (2019-2020) (Million US$)
Table 50. China Key Players Targeted DNA/RNA Sequencing Market Share (2019-2020)
Table 51. China Targeted DNA/RNA Sequencing Market Size by Type (2015-2020) (Million US$)
Table 52. China Targeted DNA/RNA Sequencing Market Share by Type (2015-2020)
Table 53. China Targeted DNA/RNA Sequencing Market Size by Application (2015-2020) (Million US$)
Table 54. China Targeted DNA/RNA Sequencing Market Share by Application (2015-2020)
Table 55. Japan Key Players Targeted DNA/RNA Sequencing Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Targeted DNA/RNA Sequencing Market Share (2019-2020)
Table 57. Japan Targeted DNA/RNA Sequencing Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Targeted DNA/RNA Sequencing Market Share by Type (2015-2020)
Table 59. Japan Targeted DNA/RNA Sequencing Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Targeted DNA/RNA Sequencing Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Targeted DNA/RNA Sequencing Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Targeted DNA/RNA Sequencing Market Share (2019-2020)
Table 63. Southeast Asia Targeted DNA/RNA Sequencing Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Targeted DNA/RNA Sequencing Market Share by Type (2015-2020)
Table 65. Southeast Asia Targeted DNA/RNA Sequencing Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Targeted DNA/RNA Sequencing Market Share by Application (2015-2020)
Table 67. India Key Players Targeted DNA/RNA Sequencing Revenue (2019-2020) (Million US$)
Table 68. India Key Players Targeted DNA/RNA Sequencing Market Share (2019-2020)
Table 69. India Targeted DNA/RNA Sequencing Market Size by Type (2015-2020) (Million US$)
Table 70. India Targeted DNA/RNA Sequencing Market Share by Type (2015-2020)
Table 71. India Targeted DNA/RNA Sequencing Market Size by Application (2015-2020) (Million US$)
Table 72. India Targeted DNA/RNA Sequencing Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Targeted DNA/RNA Sequencing Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Targeted DNA/RNA Sequencing Market Share (2019-2020)
Table 75. Central & South America Targeted DNA/RNA Sequencing Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Targeted DNA/RNA Sequencing Market Share by Type (2015-2020)
Table 77. Central & South America Targeted DNA/RNA Sequencing Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Targeted DNA/RNA Sequencing Market Share by Application (2015-2020)
Table 79. Illumina, Inc. Company Details
Table 80. Illumina, Inc. Business Overview
Table 81. Illumina, Inc. Product
Table 82. Illumina, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020) (Million US$)
Table 83. Illumina, Inc. Recent Development
Table 84. F. Hoffmann-La Roche Ltd Company Details
Table 85. F. Hoffmann-La Roche Ltd Business Overview
Table 86. F. Hoffmann-La Roche Ltd Product
Table 87. F. Hoffmann-La Roche Ltd Revenue in Targeted DNA/RNA Sequencing Business (2015-2020) (Million US$)
Table 88. F. Hoffmann-La Roche Ltd Recent Development
Table 89. Agilent Technologies Company Details
Table 90. Agilent Technologies Business Overview
Table 91. Agilent Technologies Product
Table 92. Agilent Technologies Revenue in Targeted DNA/RNA Sequencing Business (2015-2020) (Million US$)
Table 93. Agilent Technologies Recent Development
Table 94. GATC Biotech Ag Company Details
Table 95. GATC Biotech Ag Business Overview
Table 96. GATC Biotech Ag Product
Table 97. GATC Biotech Ag Revenue in Targeted DNA/RNA Sequencing Business (2015-2020) (Million US$)
Table 98. GATC Biotech Ag Recent Development
Table 99. Oxford Nanopore Technologies Company Details
Table 100. Oxford Nanopore Technologies Business Overview
Table 101. Oxford Nanopore Technologies Product
Table 102. Oxford Nanopore Technologies Revenue in Targeted DNA/RNA Sequencing Business (2015-2020) (Million US$)
Table 103. Oxford Nanopore Technologies Recent Development
Table 104. Thermo Fisher Scientific, Inc. Company Details
Table 105. Thermo Fisher Scientific, Inc. Business Overview
Table 106. Thermo Fisher Scientific, Inc. Product
Table 107. Thermo Fisher Scientific, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020) (Million US$)
Table 108. Thermo Fisher Scientific, Inc. Recent Development
Table 109. DNASTAR Inc. Company Details
Table 110. DNASTAR Inc. Business Overview
Table 111. DNASTAR Inc. Product
Table 112. DNASTAR Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020) (Million US$)
Table 113. DNASTAR Inc. Recent Development
Table 114. QIAGEN Business Overview
Table 115. QIAGEN Product
Table 116. QIAGEN Company Details
Table 117. QIAGEN Revenue in Targeted DNA/RNA Sequencing Business (2015-2020) (Million US$)
Table 118. QIAGEN Recent Development
Table 119. BGI Company Details
Table 120. BGI Business Overview
Table 121. BGI Product
Table 122. BGI Revenue in Targeted DNA/RNA Sequencing Business (2015-2020) (Million US$)
Table 123. BGI Recent Development
Table 124. Perkin Elmer, Inc. Company Details
Table 125. Perkin Elmer, Inc. Business Overview
Table 126. Perkin Elmer, Inc. Product
Table 127. Perkin Elmer, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020) (Million US$)
Table 128. Perkin Elmer, Inc. Recent Development
Table 129. Pacific Biosciences of California, Inc. Company Details
Table 130. Pacific Biosciences of California, Inc. Business Overview
Table 131. Pacific Biosciences of California, Inc. Product
Table 132. Pacific Biosciences of California, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020) (Million US$)
Table 133. Pacific Biosciences of California, Inc. Recent Development
Table 134. Bio-Rad Laboratories, Inc. Company Details
Table 135. Bio-Rad Laboratories, Inc. Business Overview
Table 136. Bio-Rad Laboratories, Inc. Product
Table 137. Bio-Rad Laboratories, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020) (Million US$)
Table 138. Bio-Rad Laboratories, Inc. Recent Development
Table 139. Integrated DNA Technologies, Inc. Company Details
Table 140. Integrated DNA Technologies, Inc. Business Overview
Table 141. Integrated DNA Technologies, Inc. Product
Table 142. Integrated DNA Technologies, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020) (Million US$)
Table 143. Integrated DNA Technologies, Inc. Recent Development
Table 144. RainDance Technologies, Inc. Company Details
Table 145. RainDance Technologies, Inc. Business Overview
Table 146. RainDance Technologies, Inc. Product
Table 147. RainDance Technologies, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020) (Million US$)
Table 148. RainDance Technologies, Inc. Recent Development
Table 149. PierianDx Company Details
Table 150. PierianDx Business Overview
Table 151. PierianDx Product
Table 152. PierianDx Revenue in Targeted DNA/RNA Sequencing Business (2015-2020) (Million US$)
Table 153. PierianDx Recent Development
Table 154. Genomatix GmbH Company Details
Table 155. Genomatix GmbH Business Overview
Table 156. Genomatix GmbH Product
Table 157. Genomatix GmbH Revenue in Targeted DNA/RNA Sequencing Business (2015-2020) (Million US$)
Table 158. Genomatix GmbH Recent Development
Table 159. Macrogen, Inc. Company Details
Table 160. Macrogen, Inc. Business Overview
Table 161. Macrogen, Inc. Product
Table 162. Macrogen, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020) (Million US$)
Table 163. Macrogen, Inc. Recent Development
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeted DNA/RNA Sequencing Market Share by Type: 2020 VS 2026
Figure 2. DNA-based Targeted Sequencing Features
Figure 3. RNA-based Targeted Sequencing Features
Figure 4. Global Targeted DNA/RNA Sequencing Market Share by Application: 2020 VS 2026
Figure 5. Human Biomedical Research Case Studies
Figure 6. Plant & Animal Sciences Case Studies
Figure 7. Drug Discovery Case Studies
Figure 8. Others Case Studies
Figure 9. Targeted DNA/RNA Sequencing Report Years Considered
Figure 10. Global Targeted DNA/RNA Sequencing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Targeted DNA/RNA Sequencing Market Share by Regions: 2020 VS 2026
Figure 12. Global Targeted DNA/RNA Sequencing Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Targeted DNA/RNA Sequencing Market Share by Players in 2019
Figure 15. Global Top Targeted DNA/RNA Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted DNA/RNA Sequencing as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Targeted DNA/RNA Sequencing Revenue in 2019
Figure 17. North America Targeted DNA/RNA Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Targeted DNA/RNA Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Targeted DNA/RNA Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Targeted DNA/RNA Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Targeted DNA/RNA Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Targeted DNA/RNA Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Targeted DNA/RNA Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Illumina, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Illumina, Inc. Revenue Growth Rate in Targeted DNA/RNA Sequencing Business (2015-2020)
Figure 26. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Targeted DNA/RNA Sequencing Business (2015-2020)
Figure 28. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Agilent Technologies Revenue Growth Rate in Targeted DNA/RNA Sequencing Business (2015-2020)
Figure 30. GATC Biotech Ag Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. GATC Biotech Ag Revenue Growth Rate in Targeted DNA/RNA Sequencing Business (2015-2020)
Figure 32. Oxford Nanopore Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Oxford Nanopore Technologies Revenue Growth Rate in Targeted DNA/RNA Sequencing Business (2015-2020)
Figure 34. Thermo Fisher Scientific, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Targeted DNA/RNA Sequencing Business (2015-2020)
Figure 36. DNASTAR Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. DNASTAR Inc. Revenue Growth Rate in Targeted DNA/RNA Sequencing Business (2015-2020)
Figure 38. QIAGEN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. QIAGEN Revenue Growth Rate in Targeted DNA/RNA Sequencing Business (2015-2020)
Figure 40. BGI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. BGI Revenue Growth Rate in Targeted DNA/RNA Sequencing Business (2015-2020)
Figure 42. Perkin Elmer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Perkin Elmer, Inc. Revenue Growth Rate in Targeted DNA/RNA Sequencing Business (2015-2020)
Figure 44. Pacific Biosciences of California, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Pacific Biosciences of California, Inc. Revenue Growth Rate in Targeted DNA/RNA Sequencing Business (2015-2020)
Figure 46. Bio-Rad Laboratories, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Targeted DNA/RNA Sequencing Business (2015-2020)
Figure 48. Integrated DNA Technologies, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Integrated DNA Technologies, Inc. Revenue Growth Rate in Targeted DNA/RNA Sequencing Business (2015-2020)
Figure 50. RainDance Technologies, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. RainDance Technologies, Inc. Revenue Growth Rate in Targeted DNA/RNA Sequencing Business (2015-2020)
Figure 52. PierianDx Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. PierianDx Revenue Growth Rate in Targeted DNA/RNA Sequencing Business (2015-2020)
Figure 54. Genomatix GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Genomatix GmbH Revenue Growth Rate in Targeted DNA/RNA Sequencing Business (2015-2020)
Figure 56. Macrogen, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Macrogen, Inc. Revenue Growth Rate in Targeted DNA/RNA Sequencing Business (2015-2020)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs